Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Santen Inc.
With
Vistakon Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Man or woman 18 years of age or older
Scheduled for corneal transplant surgery
Patients must be healthy enough to undergo surgery
Women must be postmenopausal for at least 1 year or surgically sterile incapable of pregnancy
Women must be abstinent at the discretion of the investigator
Women practicing an effective method of birth control
Women agree before entry to continue to use the same method of contraception throughout the study
Women of childbearing potential must have a negative urine pregnancy test at screening
You may not be if
Presence of an active ocular infection or positive history of ocular herpetic infection
History of severe dry eye syndrome
Use of contact lenses in the 2 weeks prior to the study and for the duration of the study
Received an experimental drug or used an experimental medical device within 30 days before the planned start of treatment
Pregnant or breast feeding
Employees of the investigator or study center with direct involvement in the proposed study or other studies under the direction of that investigator or study center as well as family members of the employees or the investigator
Clareo Health | Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery
